Researchers have identified specific proteins that drive the development of cancer stem cells. They report targeting and suppressing galectin1, in addition to radiation therapy, could be an effective treatment for glioblastoma brain cancer.
A new STING treatment induces immunological responses that allow the immune system to fight otherwise immunological resistant glioblastoma cancer cells, researchers report.
While incidence rates of malignant brain cancers have declined over recent years, the five-year survival rate for brain cancer patients remains low.
Researchers have successfully replicated an entire, viable glioblastoma brain tumor via 3D bioprinting. The bioprinted tumor includes a complex system of blood vessel-like tubes through which blood cells and drug molecules can flow, simulating a real tumor.
A new AI model can accurately classify a brain tumor of one of six common cancer types from a single MRI brain scan image.
A new study reports cancer patients who frequently eat peanuts may be at increased risk of their cancer spreading. Researchers found Peanut agglutinin (PNA), a carbohydrate-binding protein that enters blood circulation after a peanut is eaten, interacts with endothelial cells to produce cytokines. Some of the cytokines are recognized promoters of cancer metastasis.
Cancer patients with vitamin D deficiency under palliative care reported a decreased need for opioids to control pain and reduced symptoms of fatigue when given vitamin D supplementation.
Two newly developed tests, one which analyzes urine samples and a simple blood test, can detect the presence of glioma brain cancer.
A novel helmet that generates a noninvasive oscillating magnetic field was able to reduce tumor mass by 31% in a glioblastoma brain cancer patient.
Cell phone radiation increases the risk for a number of biological and health disorders, including gliomas and acoustic neuroma brain cancer. Researchers discuss how to reduce the risk of cell phone radiation.
Researchers found lymph-node-like structures close to glioma brain tumors in cancer patients. The study reveals immune cells within these structures can be activated to attack the brain tumor.
Changes in taste perception can for years following chemotherapy and radiotherapy treatments for cancer, a new study reports. Cancer survivors reported less sensitivity to bitter, sweet, and salty tastes compared to those who never received a cancer diagnosis. Taste buds on the tip of the tongue are most affected.
